Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-09-15
Bourla Albert Files Pfizer (PFE) Form 4 - September 15, 2026
Bourla Albert reported holdings changes in PFE in this Form 4 filing, reported to the SEC on 2026-09-15.
- Insider
- Bourla Albert
- Issuer
- Pfizer Inc. PFE · NYSE
- Filed
- Period
- 2026-09-15
- Accession
- 0001225208-26-007840
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| No transactions found | ||||||
About Pfizer Inc.
Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines for people worldwide. Its current portfolio spans oncology, vaccines, internal medicine, inflammation and immunology, rare diseases, and hospital-based care, supported by a broad commercial network that serves physicians, hospitals, pharmacies, governments, and healthcare systems. Pfizer also maintains a consumer health presence through established over-the-counter and wellness products in select markets. The company plays a central role in global healthcare by supplying prescription therapies and immunizations across major therapeutic areas, while its research and development organization continues to support the launch, approval, and lifecycle management of new treatments. Founded in 1849 and headquartered in New York City, Pfizer Inc. remains one of the most recognized names in the pharmaceutical industry.
Track PFE insider activity
Get alerted when Pfizer Inc. executives buy or sell their shares.